ID   ULK3_HUMAN              Reviewed;         472 AA.
AC   Q6PHR2; B2RXK3; B4DFT0; B4DRQ7; D3DW68; Q9NPN5; Q9UFS4;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=Serine/threonine-protein kinase ULK3;
DE            EC=2.7.11.1;
DE   AltName: Full=Unc-51-like kinase 3;
GN   Name=ULK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Amygdala, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Blood, and Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 162-472 (ISOFORM 2).
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-176, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=19279323; DOI=10.1101/gad.519709;
RA   Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M.,
RA   Darot J.F., Tavare S., Arakawa S., Shimizu S., Watt F.M., Narita M.;
RT   "Autophagy mediates the mitotic senescence transition.";
RL   Genes Dev. 23:798-803(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-44 AND LYS-139.
RX   PubMed=19878745; DOI=10.1016/j.yexcr.2009.10.018;
RA   Maloverjan A., Piirsoo M., Michelson P., Kogerman P., Osterlund T.;
RT   "Identification of a novel serine/threonine kinase ULK3 as a positive
RT   regulator of Hedgehog pathway.";
RL   Exp. Cell Res. 316:627-637(2010).
RN   [10]
RP   FUNCTION, AUTOPHOSPHORYLATION, INTERACTION WITH SUFU, MUTAGENESIS OF
RP   LYS-139, AND PHOSPHORYLATION AT SER-300; SER-350; SER-384 AND SER-464.
RX   PubMed=20643644; DOI=10.1074/jbc.M110.133991;
RA   Maloverjan A., Piirsoo M., Kasak L., Peil L., Osterlund T.,
RA   Kogerman P.;
RT   "Dual function of UNC-51-like kinase 3 (Ulk3) in the Sonic hedgehog
RT   signaling pathway.";
RL   J. Biol. Chem. 285:30079-30090(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Serine/threonine protein kinase that acts as a regulator
CC       of Sonic hedgehog (SHH) signaling and autophagy. Acts as a
CC       negative regulator of SHH signaling in the absence of SHH ligand:
CC       interacts with SUFU, thereby inactivating the protein kinase
CC       activity and preventing phosphorylation of GLI proteins (GLI1,
CC       GLI2 and/or GLI3). Positively regulates SHH signaling in the
CC       presence of SHH: dissociates from SUFU, autophosphorylates and
CC       mediates phosphorylation of GLI2, activating it and promoting its
CC       nuclear translocation. Phosphorylates in vitro GLI2, as well as
CC       GLI1 and GLI3, although less efficiently. Also acts as a regulator
CC       of autophagy: following cellular senescence, able to induce
CC       autophagy. {ECO:0000269|PubMed:19279323,
CC       ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:20643644}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts (via protein kinase domain) with SUFU.
CC       {ECO:0000269|PubMed:20643644}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19279323,
CC       ECO:0000269|PubMed:19878745}. Note=Localizes to pre-autophagosomal
CC       structure during cellular senescence.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6PHR2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PHR2-2; Sequence=VSP_038147, VSP_038148;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q6PHR2-3; Sequence=VSP_039925;
CC         Note=May be due to competing donor splice site. No experimental
CC         confirmation available.;
CC       Name=4;
CC         IsoId=Q6PHR2-4; Sequence=VSP_057411;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels observed in
CC       fetal brain. In adult tissues, high levels in brain, liver and
CC       kidney, moderate levels in testis and adrenal gland and low levels
CC       in heart, lung, stomach, thymus, prostate and placenta. In the
CC       brain, highest expression in the hippocampus, high levels also
CC       detected in the cerebellum, olfactory bulb and optic nerve. In the
CC       central nervous system, lowest levels in the spinal cord.
CC       {ECO:0000269|PubMed:19878745}.
CC   -!- INDUCTION: Up-regulated during senescence.
CC       {ECO:0000269|PubMed:19279323}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation is blocked by
CC       interaction with SUFU. {ECO:0000269|PubMed:20643644}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. APG1/unc-51/ULK1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB55955.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294245; BAG57541.1; -; mRNA.
DR   EMBL; AK299380; BAG61369.1; -; mRNA.
DR   EMBL; AL117482; CAB55955.2; ALT_INIT; mRNA.
DR   EMBL; AC091230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036117; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC056423; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471136; EAW99301.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99303.1; -; Genomic_DNA.
DR   EMBL; BC157884; AAI57885.1; -; mRNA.
DR   EMBL; AL360256; CAB96176.1; -; mRNA.
DR   CCDS; CCDS45305.1; -. [Q6PHR2-1]
DR   CCDS; CCDS76779.1; -. [Q6PHR2-3]
DR   PIR; T17265; T17265.
DR   RefSeq; NP_001092906.3; NM_001099436.3. [Q6PHR2-1]
DR   RefSeq; NP_001271293.2; NM_001284364.2. [Q6PHR2-3]
DR   RefSeq; NP_001271294.1; NM_001284365.2.
DR   RefSeq; XP_005254346.1; XM_005254289.2. [Q6PHR2-4]
DR   UniGene; Hs.513034; -.
DR   PDB; 4WZX; X-ray; 1.39 A; A=359-449.
DR   PDBsum; 4WZX; -.
DR   ProteinModelPortal; Q6PHR2; -.
DR   SMR; Q6PHR2; -.
DR   BioGrid; 117470; 7.
DR   IntAct; Q6PHR2; 1.
DR   STRING; 9606.ENSP00000400312; -.
DR   BindingDB; Q6PHR2; -.
DR   ChEMBL; CHEMBL5047; -.
DR   GuidetoPHARMACOLOGY; 2273; -.
DR   iPTMnet; Q6PHR2; -.
DR   PhosphoSitePlus; Q6PHR2; -.
DR   DMDM; 259016166; -.
DR   EPD; Q6PHR2; -.
DR   MaxQB; Q6PHR2; -.
DR   PaxDb; Q6PHR2; -.
DR   PeptideAtlas; Q6PHR2; -.
DR   PRIDE; Q6PHR2; -.
DR   DNASU; 25989; -.
DR   Ensembl; ENST00000440863; ENSP00000400312; ENSG00000140474. [Q6PHR2-1]
DR   Ensembl; ENST00000568667; ENSP00000457853; ENSG00000140474. [Q6PHR2-4]
DR   Ensembl; ENST00000569437; ENSP00000456051; ENSG00000140474. [Q6PHR2-3]
DR   GeneID; 25989; -.
DR   KEGG; hsa:25989; -.
DR   UCSC; uc010ulq.3; human.
DR   UCSC; uc059llp.1; human. [Q6PHR2-1]
DR   CTD; 25989; -.
DR   DisGeNET; 25989; -.
DR   GeneCards; ULK3; -.
DR   H-InvDB; HIX0012431; -.
DR   HGNC; HGNC:19703; ULK3.
DR   HPA; HPA040474; -.
DR   MIM; 613472; gene.
DR   neXtProt; NX_Q6PHR2; -.
DR   OpenTargets; ENSG00000140474; -.
DR   PharmGKB; PA134908392; -.
DR   eggNOG; KOG0595; Eukaryota.
DR   eggNOG; ENOG410XR01; LUCA.
DR   GeneTree; ENSGT00870000136410; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG094133; -.
DR   InParanoid; Q6PHR2; -.
DR   KO; K21358; -.
DR   OMA; ALHYEAD; -.
DR   OrthoDB; EOG091G0JGC; -.
DR   PhylomeDB; Q6PHR2; -.
DR   TreeFam; TF324551; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   SignaLink; Q6PHR2; -.
DR   GenomeRNAi; 25989; -.
DR   PRO; PR:Q6PHR2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140474; -.
DR   CleanEx; HS_ULK3; -.
DR   ExpressionAtlas; Q6PHR2; baseline and differential.
DR   Genevisible; Q6PHR2; HS.
DR   GO; GO:0097542; C:ciliary tip; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000407; C:pre-autophagosomal structure; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006914; P:autophagy; TAS:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; TAS:UniProtKB.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR007330; MIT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF04212; MIT; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00745; MIT; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF116846; SSF116846; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Autophagy;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    472       Serine/threonine-protein kinase ULK3.
FT                                /FTId=PRO_0000250150.
FT   DOMAIN       14    270       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      280    348       MIT 1.
FT   DOMAIN      375    444       MIT 2.
FT   NP_BIND      20     28       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    137    137       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      44     44       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     176    176       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     300    300       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20643644}.
FT   MOD_RES     350    350       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20643644}.
FT   MOD_RES     384    384       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20643644}.
FT   MOD_RES     464    464       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20643644}.
FT   VAR_SEQ       1     34       MAGPGWGPPRLDGFILTERLGSGTYATVYKAYAK -> MQR
FT                                NGSASRGLEKTRLRLCREARIPESAFLTGLTRESWEARCWC
FT                                A (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057411.
FT   VAR_SEQ     205    214       EALFGQPPFA -> GETSFPCFSP (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_038147.
FT   VAR_SEQ     215    472       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_038148.
FT   VAR_SEQ     444    445       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039925.
FT   VARIANT     101    101       R -> H (in dbSNP:rs34945944).
FT                                /FTId=VAR_057113.
FT   VARIANT     445    445       K -> R (in dbSNP:rs12898397).
FT                                /FTId=VAR_059771.
FT   MUTAGEN      44     44       K->R: Decreased kinase activity.
FT                                {ECO:0000269|PubMed:19878745}.
FT   MUTAGEN     139    139       K->R: Loss of kinase activity. Does not
FT                                promote GLI1 nuclear localization.
FT                                {ECO:0000269|PubMed:19878745,
FT                                ECO:0000269|PubMed:20643644}.
FT   CONFLICT     47     47       A -> S (in Ref. 1; BAG61369).
FT                                {ECO:0000305}.
FT   HELIX       362    369       {ECO:0000244|PDB:4WZX}.
FT   TURN        370    372       {ECO:0000244|PDB:4WZX}.
FT   HELIX       374    390       {ECO:0000244|PDB:4WZX}.
FT   HELIX       396    416       {ECO:0000244|PDB:4WZX}.
FT   HELIX       421    445       {ECO:0000244|PDB:4WZX}.
SQ   SEQUENCE   472 AA;  53444 MW;  11D03E311AF36162 CRC64;
     MAGPGWGPPR LDGFILTERL GSGTYATVYK AYAKKDTREV VAIKCVAKKS LNKASVENLL
     TEIEILKGIR HPHIVQLKDF QWDSDNIYLI MEFCAGGDLS RFIHTRRILP EKVARVFMQQ
     LASALQFLHE RNISHLDLKP QNILLSSLEK PHLKLADFGF AQHMSPWDEK HVLRGSPLYM
     APEMVCQRQY DARVDLWSMG VILYEALFGQ PPFASRSFSE LEEKIRSNRV IELPLRPLLS
     RDCRDLLQRL LERDPSRRIS FQDFFAHPWV DLEHMPSGES LGRATALVVQ AVKKDQEGDS
     AAALSLYCKA LDFFVPALHY EVDAQRKEAI KAKVGQYVSR AEELKAIVSS SNQALLRQGT
     SARDLLREMA RDKPRLLAAL EVASAAMAKE EAAGGEQDAL DLYQHSLGEL LLLLAAEPPG
     RRRELLHTEV QNLMARAEYL KEQVKMRESR WEADTLDKEG LSESVRSSCT LQ
//
